dipropylacetamide

Known as: 2-ethylvaleramide, valproic acid amide, valpromide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Maternal use of valproic acid (VPA) during pregnancy has been implicated in the aetiology of autism spectrum disorders in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Imbalance in excitatory/inhibitory signal in the brain has been proposed as one of the main pathological features in autism… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
OBJECTIVES Agomelatine has been shown to be safe and efficient in the treatment of major depressive disorder at 25 mg daily. The… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Valproic acid (VPA) has been used as an anticonvulsant agent for the treatment of epilepsy, as well as a mood stabilizer for the… (More)
Is this relevant?
2005
2005
Inositol-1,4,5-trisphosphate (InsP3) depletion has been implicated in the therapeutic action of bipolar disorder drugs, including… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Lithium and valproate (VPA) are used for treating bipolar disorder. The mechanism of mood stabilization has not been… (More)
Is this relevant?
2004
2004
Adipogenesis is dependent on the sequential activation of transcription factors including the CCAAT/enhancer-binding proteins (C… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2003
Highly Cited
2003
In this report, we demonstrate that valproic acid (VPA), a drug that has been used for decades in the treatment of epilepsy and… (More)
Is this relevant?
Review
1996
Review
1996
Carbamazepine is one of the most commonly prescribed antiepileptic drugs and is also used in the treatment of trigeminal… (More)
Is this relevant?
1986
1986
  • Heinz Nau
  • Environmental health perspectives
  • 1986
Interspecies differences in regard to the teratogenicity of drugs can be the result of differing pharmacokinetic processes that… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?